Earnings calendar/ADMA
ADMA Biologics, Inc. (ADMA)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 4, 2026
Consensus estimate row
EPS target
$0.19
Street estimate
Revenue target
$138.1M
Street estimate
Trailing EPS (avg 4Q)
$0.18
Beat rate last 4: 50%
Latest EPS YoY
+6.7%
vs 2025-08-06
Latest revenue YoY
+2.0%
How results look so far
Trailing revenue (avg 4Q)
$128.1M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS miss
EPS actual / est
$0.16 / $0.16
-2.0%
Revenue actual / est
$124.4M / $125.3M
-0.8%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/4/2026upcoming | $0.19 | Pending | — | $138.1M | Pending | — |
| 8/5/2026 | $0.16 | $0.16 | -2.0% | $125.3M | $124.4M | -0.8% |
| 5/6/2026 | $0.19 | $0.19 | -1.7% | $140.0M | $114.5M | -18.2% |
| 3/2/2026upcoming | $0.20 | Pending | — | $139.8M | Pending | — |
| 2/25/2026 | $0.18 | $0.20 | +8.1% | $139.6M | $139.2M | -0.3% |
| 11/5/2025 | $0.16 | $0.16 | 0.0% | $139.8M | $134.2M | -4.0% |
| 8/6/2025 | $0.14 | $0.15 | +7.1% | $130.3M | $122.0M | -6.4% |
| 5/7/2025 | $0.16 | $0.14 | -12.5% | $121.8M | $114.8M | -5.7% |
| 3/3/2025 | $0.15 | $0.14 | -6.7% | $108.7M | $117.5M | +8.2% |
| 11/7/2024 | $0.13 | $0.15 | +15.4% | $113.4M | $119.8M | +5.7% |
| 8/8/2024 | $0.08 | $0.13 | +62.5% | $86.4M | $107.2M | +24.0% |
| 5/9/2024 | $0.06 | $0.08 | +33.3% | $77.3M | $81.9M | +6.0% |
| 2/28/2024 | $-0.01 | $0.04 | +420.0% | $72.2M | $73.9M | +2.4% |
| 11/8/2023 | $0.00 | $0.01 | +233.3% | $68.5M | $67.3M | -1.8% |
| 8/9/2023 | $-0.02 | $-0.02 | -19.8% | $55.5M | $60.1M | +8.3% |
| 5/10/2023 | $-0.05 | $-0.03 | +40.0% | $53.4M | $56.9M | +6.6% |
| 3/23/2023 | $-0.07 | $-0.06 | +14.3% | $45.9M | $50.0M | +8.8% |
| 11/9/2022 | $-0.08 | $-0.08 | 0.0% | $34.5M | $41.1M | +19.2% |
| 8/10/2022 | $-0.09 | $-0.07 | +22.2% | $31.8M | $33.9M | +6.6% |
| 5/11/2022 | $-0.08 | $-0.10 | -25.0% | $25.9M | $29.1M | +12.4% |
| 3/24/2022 | $-0.10 | $-0.09 | +10.0% | $21.8M | $26.4M | +21.3% |
| 11/10/2021 | $-0.15 | $-0.13 | +13.3% | $23.4M | $20.7M | -11.8% |
| 8/11/2021 | $-0.15 | $-0.15 | 0.0% | $17.8M | $17.8M | -0.0% |
| 5/12/2021 | $-0.17 | $-0.16 | +5.9% | $14.6M | $16.0M | +10.3% |
| 3/25/2021 | $-0.17 | $-0.20 | -17.6% | — | $14.0M | — |
| 11/5/2020 | $-0.21 | $-0.19 | +9.5% | $10.3M | $10.3M | 0.0% |
| 8/5/2020 | $-0.19 | $-0.23 | -21.1% | $5.4M | $7.8M | +43.8% |
| 5/6/2020 | $-0.13 | $-0.26 | -100.0% | $9.5M | $10.2M | +7.7% |
| 3/12/2020 | $-0.20 | $-0.18 | +10.0% | $11.4M | $12.0M | +5.9% |
| 11/6/2019 | $-0.22 | $-0.19 | +13.6% | $8.7M | $7.2M | -17.4% |
| 8/8/2019 | $-0.26 | $-0.25 | +3.8% | $7.6M | $6.6M | -13.8% |
| 5/8/2019 | $-0.32 | $-0.31 | +3.1% | $4.0M | $3.5M | -12.5% |
| 3/13/2019 | $-0.33 | $-0.39 | -18.2% | $3.6M | $4.1M | +11.4% |
| 11/8/2018 | $-0.33 | $-0.33 | 0.0% | $4.0M | $4.2M | +6.5% |
| 8/10/2018 | $-0.32 | $-0.35 | -9.4% | $4.1M | $4.7M | +12.9% |
| 5/14/2018 | $-0.27 | $-0.35 | -29.6% | $3.2M | $4.0M | +25.8% |
| 3/5/2018 | $-0.51 | $-0.24 | +52.9% | $12.8M | $12.0M | -6.5% |
| 11/3/2017 | $-0.51 | $0.59 | +215.7% | $3.4M | $4.7M | +38.1% |
| 8/11/2017 | $-0.42 | $-0.55 | -31.0% | $2.5M | $3.4M | +34.7% |
| 5/12/2017 | $-0.22 | $-0.51 | -131.8% | $2.6M | $2.6M | +0.6% |
| 2/24/2017 | $-0.33 | $-0.35 | -6.1% | $3.0M | $3.3M | +9.4% |
| 11/10/2016 | $-0.40 | $-0.34 | +15.0% | $3.6M | $2.9M | -19.0% |
| 8/12/2016 | $-0.38 | $-0.50 | -31.6% | $1.7M | $2.3M | +31.6% |
| 5/13/2016 | $-0.45 | $-0.43 | +4.4% | $1.8M | $2.1M | +16.2% |
| 3/23/2016 | $-0.47 | $-0.44 | +6.4% | $2.5M | $2.5M | +2.3% |
| 11/10/2015 | $-0.39 | $-0.48 | -23.1% | $1.5M | $1.9M | +23.1% |
| 8/11/2015 | $-0.32 | $-0.37 | -15.6% | $1.0M | $1.3M | +25.7% |
| 5/12/2015 | $-0.32 | $-0.37 | -15.6% | $1.5M | $1.5M | -2.6% |
| 3/9/2015 | $-0.41 | $-0.38 | +7.3% | $1.5M | $1.5M | 0.0% |
| 11/10/2014 | $-0.37 | $-0.36 | +2.7% | $1.4M | $1.4M | -2.7% |
| 8/11/2014 | $-0.52 | $-0.43 | +17.3% | $3.7M | $1.5M | -59.5% |
| 5/12/2014 | $-0.49 | $-0.64 | -30.6% | $1.19B | $1.6M | -99.9% |
| 3/28/2014 | $-0.47 | $-0.54 | -14.9% | $369,064.02 | $1.1M | +200.0% |
| 8/12/2013 | — | $-0.83 | — | — | $743,270 | — |
| 5/14/2013 | — | $-0.55 | — | — | $792,935 | — |
| 3/6/2013 | — | $-0.48 | — | — | $523,284 | — |
| 11/13/2012 | — | $-0.55 | — | — | $360,338 | — |
| 8/14/2012 | — | $-0.20 | — | — | $230,096 | — |
| 5/15/2012 | — | $-0.18 | — | — | $4,400 | — |
| 2/1/2012 | — | $-0.00 | — | — | Pending | — |
| 10/28/2011 | — | $-0.00 | — | — | Pending | — |
| 9/27/2011 | — | $-0.00 | — | — | Pending | — |
| 5/10/2011 | — | $-0.00 | — | — | Pending | — |
| 1/27/2011 | — | $-0.00 | — | — | Pending | — |
| 10/22/2010 | — | $-0.00 | — | — | Pending | — |
| 9/23/2010 | — | $-0.00 | — | — | Pending | — |
| 4/27/2010 | — | $-0.00 | — | — | Pending | — |
| 1/29/2010 | — | $-0.00 | — | — | Pending | — |
| 11/9/2009 | — | $-1.53 | — | — | Pending | — |
| 9/24/2009 | — | $-8.00 | — | — | Pending | — |
| 4/27/2009 | — | $-4.38 | — | — | Pending | — |
| 1/14/2009 | — | $-2.85 | — | — | Pending | — |
| 9/12/2008 | — | $-9.96 | — | — | Pending | — |
| 4/8/2008 | — | $-0.01 | — | — | Pending | — |
| 2/12/2008 | — | $-0.00 | — | — | Pending | — |
| 10/24/2007 | — | $-0.00 | — | — | Pending | — |
| 8/16/2007 | — | $-0.01 | — | — | Pending | — |
| 4/25/2007 | — | $-0.01 | — | — | Pending | — |
| 1/30/2007 | — | $-0.01 | — | — | Pending | — |
| 10/19/2006 | — | $-0.01 | — | — | Pending | — |
Need ADMA data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.